Evidence map›Paper›PMID 39474070›Full record

ArticleiScience2024

Analyzing sex imbalance in EGA and dbGaP biological databases: Recommendations for better practices.

Victoria Ruiz-Serra, Nataly Buslón, Olivier R Philippe, Diego Saby, María Morales, Camila Pontes, Alejandro Muñoz Andirkó, Gemma L Holliday, Aina Jené, Mauricio Moldes and 5 more

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Sex and Gender Dimensions in Hazard and Risk Assessment of Engineered Nanomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Victoria Ruiz-SerraLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Nataly BuslónWeb Science and Social Computing Group Department of Engineering, Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.
Olivier R PhilippeLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Diego SabyData Science Unit, LHF Labs S.L, 48020 Bilbao, Spain.
María MoralesLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Camila PontesLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Alejandro Muñoz AndirkóCognitive Biology of Language Group, University of Barcelona, 08007 Barcelona, Spain.
Gemma L HollidayMedicines Discovery Catapult, Mereside, Macclesfield SK10 4ZF, UK.
Aina JenéComputational Biology and Health Genomics Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
Mauricio MoldesComputational Biology and Health Genomics Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
Jordi RamblaComputational Biology and Health Genomics Programme, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.
Alfonso ValenciaLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
María José RementeriaLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Atia CortésLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.
Davide CirilloLife Sciences, Barcelona Supercomputing Center (BSC), 08034 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision medicine aims at tailoring treatments to individual patient's characteristics. In this regard, recognizing the significance of sex and gender becomes indispensable for meeting the distinct healthcare needs of diverse populations. To this end, continuing a trend of improving data quality observed since 2014, the European Genome-phenome Archive (EGA) established a policy in 2018 that mandates data providers to declare the sex of donor samples, aiming to enhance data accuracy and prevent imbalance in sex classification. We analyzed sex classification imbalance in human data from EGA and the U.S. counterpart, the database of genotypes and phenotypes (dbGaP). Our findings show a significant decrease in samples classified as unknown in EGA, potentially promoting better sex reporting during data collection. Based on our findings, we raise awareness of sample imbalance problems and provide a list of recommendations for enhancing biomedical research practices.

Indexed as

Artificial intelligenceGenomicsHuman genetics

Identifiers

PMID39474070
PMCPMC11519560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.